Estradiol and phytoestrogens differently influence the rodent postmenopausal mammary gland

被引:17
作者
Gallo, D
Zannoni, GF
Martinelli, E
Ferlini, C
Fabrizi, M
Riva, A
Morazzoni, P
Bombardelli, E
Scambia, G
机构
[1] Univ Sacred Heart, Dept Obstet & Gynecol, I-20123 Milan, Italy
[2] Univ Sacred Heart, Dept Histopathol, I-20123 Milan, Italy
[3] INDENA SpA, Milan, Italy
来源
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2006年 / 13卷 / 01期
关键词
soy; phytoestrogens; menopause; rat; mammary gland;
D O I
10.1097/01.gme.0000191208.05491.94
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: In the following study, we investigated treatment-related changes in mammary gland histomorphology and structure after the administration of soy to adult virgin ovariectomized (OVX) female rats. Additionally, mammary receptor regulation was extensively evaluated by immunohistochemical analysis, and tissue proliferative activity analyzed by cell nuclear proliferating antigen expression (Ki67). Design: OVX rats were treated, for 6 weeks, with either the vehicle, the soy extract (SSE 100 mg/kg/d PO), or 17 beta-estradiol (0.5 mg/kg/d PO); a sham control group (SHAM) was also included in the study. When killed, mammary glands were collected and subsequently processed for light microscopy or immunohistochemistry. Immunoreactivity was quantified by a scoring system that took into account both the percentage of positive cells and the intensity of the staining. Results: The 17 beta-estradiol-treated rats had stimulated mammary glands compared with OVX rats, with an average lobulo-alveolar development not different from the SHAM controls. Only a partial regression of the glandular atrophy was observed in OVX rats receiving 100 mg/kg/d SSE, with a histological appearance between that of the OVX and SHAM controls. No significant changes were observed among experimental groups in the median ER alpha scores of the epithelial compartment (score of 3 in all groups); in the stromal compartment, a tendency toward decreased expression was seen with 17 beta-estradiol rats compared with OVX controls (scores of 2 and 5, respectively). A significant reduction in ER beta immunostaining was observed in the mammary glands of SSE-treated rats, in both epithelium and stroma (scores of 4 and 3, respectively), compared with those of OVX controls (score of 8 in both compartments). The ER beta receptor status was not significantly affected by 17 beta-estradiol. Compared with OVX rats (score of 1), PR expression was up-regulated by 17 beta-estradiol (score of 6), whereas an ovariectomy-like pattern was observed after the administration of SSE (score of 0). K167 immunoreactivity in the epithelium and stroma was increased by the administration of 17 beta-estradiol (scores of 4 and 5, respectively) and was unchanged after SSE treatment (scores of 0 and 2, respectively), compared with OVX controls (scores of I and 2, respectively). Conclusions: The differences observed in the histological pattern, hormonal receptor status regulation, and K167 modulation suggest a different role for phytoestrogens and 17 beta-estradiol in postmenopausal rodent mammary glands.
引用
收藏
页码:72 / 79
页数:8
相关论文
共 23 条
[1]   Steroid receptors and cell cycle in normal mammary epithelium [J].
Anderson, E ;
Clarke, RB .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2004, 9 (01) :3-13
[2]   Why a consensus conference on hormone replacement therapy and the cardiovascular system? [J].
Benagiano, G ;
Farris, M .
MATURITAS, 2004, 47 (04) :245-253
[3]  
Beral Valerie, 2003, Lancet, V362, P419, DOI 10.1016/S0140-6736(03)14065-2
[4]   Estrogen receptors ERα and ERβ in proliferation in the rodent mammary gland [J].
Cheng, GJ ;
Zhang, WH ;
Warner, M ;
Gustafsson, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (11) :3739-3746
[5]   Progesterone receptors in mammary gland development and tumorigenesis [J].
Conneely, OM ;
Jericevic, BM ;
Lydon, JP .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2003, 8 (02) :205-214
[6]   Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile [J].
Gallo, D ;
Zannoni, GF ;
Apollonio, P ;
Martinelli, E ;
Ferlini, C ;
Passetti, G ;
Riva, A ;
Morazzoni, P ;
Bombardelli, E ;
Scambia, G .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (05) :589-600
[7]   Cardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II) [J].
Grady, D ;
Herrington, D ;
Bittner, V ;
Blumenthal, R ;
Davidson, M ;
Hlatky, M ;
Hsia, J ;
Hulley, S ;
Herd, A ;
Khan, S ;
Newby, LK ;
Waters, D ;
Vittinghoff, E ;
Wenger, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (01) :49-57
[8]  
Hayat MA., 2002, MICROSCOPY IMMUNOHIS, P276
[9]   Estrogen plus progestin and the risk of coronary heart disease [J].
Manson, JE ;
Hsia, J ;
Johnson, KC ;
Rossouw, JE ;
Assaf, AR ;
Lasser, NL ;
Trevisan, M ;
Black, HR ;
Heckbert, SR ;
Detrano, R ;
Strickland, OL ;
Wong, ND ;
Crouse, JR ;
Stein, E ;
Cushman, M ;
Alving, B ;
Rossouw, JE ;
Pottern, L ;
Ludlam, S ;
McGowan, JA ;
Prentice, R ;
Anderson, G ;
LaCroix, A ;
Patterson, R ;
McTiernan, A ;
Cochrane, B ;
Hunt, J ;
Tinker, L ;
Kooperberg, C ;
McIntosh, M ;
Wang, CY ;
Chen, C ;
Bowen, D ;
Kristal, A ;
Stanford, J ;
Urban, N ;
Weiss, N ;
White, E ;
Shumaker, S ;
Rautaharju, P ;
Prineas, R ;
Naughton, M ;
Stein, E ;
Laskarzewski, P ;
Cummings, S ;
Nevitt, M ;
Dockrell, M ;
Harnack, L ;
Cammarata, F ;
Lindenfelser, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06) :523-534
[10]   Postmenopausal hormone-replacement therapy. [J].
Manson, JE ;
Martin, KA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) :34-U6